Measurement-Based Care (MBC) has become a significant focus in the world of behavioral health, with growing adoption among both providers and payers. The concept behind MBC is straightforward: using clinical assessments and data to track patient progress over time, ensuring that interventions are effective and that care is properly tailored to individual needs. However, a crucial and often overlooked issue remains: many clinicians are deeply skeptical of payers’ use of the data shared through clinical assessments, particularly when it comes to issues of privacy and data use.
As part of an increasing push to demonstrate the effectiveness of behavioral health interventions, Measurement-Based Care metrics often include clinical assessments like the PHQ-9, GAD-7, or other standardized tools. These assessments offer a snapshot of a patient’s mental health at a given moment, and their use can help clinicians understand where a patient stands in terms of their symptoms. However, despite the growing use of MBC metrics, many therapists are questioning how this data will be used by health insurers, especially given the evolving relationship between healthcare providers and payers.
Alma, a digital behavioral health company, recently conducted a survey of 224 therapists to explore these concerns in greater depth. The survey results shed light on how clinicians are approaching the concept of Measurement-Based Care and their reservations about its application. The findings revealed that while 87% of therapists reported using clinical assessments in some capacity, only 40% felt that these assessments were genuinely useful in tracking patients’ progress over time. The fundamental issue, as Dr. Harry Ritter, CEO of Alma, points out, is that clinical assessments are often just snapshots of a patient’s condition at a single point in time. A PHQ-9 score, for example, could vary depending on external factors—like the stress of a difficult conversation or the joy of spending time with loved ones—rendering it not entirely reliable as a constant measure of progress.
The Uncertainty and Risk of Data Use
For therapists, the major concern lies in how payers will use the data from clinical assessments. The widespread belief is that insurance companies may use these assessments to limit care or restrict coverage based on patient data. Almost 77% of therapists in Alma’s survey expressed doubts about how payers would handle clinical assessment data, with many fearing that insurers could use the information to reduce or shorten the length of time for which patients are covered. Nearly half of the surveyed therapists also raised concerns that payers might use the data to unfairly judge the effectiveness of their care.
This sense of skepticism and mistrust is not unfounded. Dr. Ritter comments that the current state of trust between behavioral health providers and payers is a clear barrier to successful adoption of Measurement-Based Care. Clinicians are understandably hesitant to share sensitive patient data unless they have confidence that the information will be used for patient care and not as a tool for reducing reimbursements or cutting down on treatment duration. In a system where reimbursement rates are often tied to the perceived effectiveness of care, these concerns are legitimate. The trauma from previous experiences with insurance companies, where denials or delays in approval for treatment are common, has left “scar tissue” among therapists, making it difficult to trust that payers will act in their patients’ best interests.
The shift toward data-driven decision-making is certainly not a new one, with numerous studies indicating that data-informed care yields better results. Dr. Ravi Shah, Chief Medical Officer at Geode Health, emphasizes that multiple meta-analyses have shown that clinicians who utilize Measurement-Based Care are more effective in delivering care than those who do not, even if the same clinician is involved. This underscores the potential benefits of MBC—but only if providers can be convinced to fully embrace it. For that to happen, it is essential that payers work harder to establish trust with clinicians, and demonstrate that the data is being used for the betterment of patient care, not just for administrative or financial purposes.
The Path Forward: Building Trust and Collaboration
While many providers are still wary of MBC, there are some signs that collaboration between clinicians and payers could help bridge the trust gap. Dr. Douglas Nemecek, Chief Medical Officer of Behavioral Health at Evernorth (the health services division of Cigna), stresses the importance of collaboration between health plans and therapists when developing Measurement-Based Care metrics. By including providers in the development of these metrics, payers can ensure that the data being collected is meaningful to clinicians and beneficial to patient care. Nemecek adds that it is crucial that clinicians understand that the data collected through these assessments is being used to inform and improve patient care—not simply to reduce reimbursements or cut down on services.
Ultimately, trust will be key. Providers need to feel confident that the data they provide will not be used against them or their patients. To that end, more communication and transparency between clinicians and payers are essential. As the behavioral health space continues to move toward a more data-driven approach, health plans must make clear their intentions and demonstrate that they prioritize patient care over cost-cutting measures.
Holistic Care Metrics Beyond Clinical Assessments
While clinical assessments are valuable, many therapists feel they do not paint a complete picture of a patient’s health. In fact, many providers are now focusing on a more holistic approach to measuring patient progress, one that includes factors beyond the scope of traditional clinical assessments. For example, more than half of the providers surveyed by Alma said that improving client functioning was one of the most important factors in assessing therapy success. Others cited the strength of the patient-therapist relationship, the reduction in client symptoms, and the alignment between the patient’s goals and the therapist’s treatment approach as key indicators of progress.
These holistic metrics are helping to shape a more well-rounded understanding of what constitutes effective behavioral health treatment. However, while clinical assessments are one important component of the patient picture, many clinicians are increasingly turning to broader measures that account for the totality of a patient’s wellbeing. This expanded view of patient care underscores the limitations of traditional Measurement-Based Care metrics and calls for more comprehensive approaches that factor in relational, emotional, and functional improvements.
The Privacy Dilemma: Concerns About Tech Platforms
As the use of technology to track and store patient data continues to grow, another concern looms large: privacy. More than half of the therapists surveyed expressed concerns about the privacy of their patients’ data when using third-party platforms. Only about one-fifth of therapists said they were confident they understood how their clients’ clinical data is used by these tech platforms. This lack of transparency about data use only compounds the skepticism surrounding Measurement-Based Care and adds another layer of complexity to its adoption.
To address these concerns, Dr. Shah suggests that clinical assessments and scales should be treated with the same level of privacy protection as a patient’s protected health information (PHI). This would ensure that sensitive patient data remains secure while still being used for its intended purpose—improving patient care. Clinicians are more likely to trust the system if they feel their patients’ privacy is being safeguarded.
Conclusion: The Road Ahead for Measurement-Based Care
Despite the challenges and skepticism surrounding MBC, the reality is that the trend toward data-driven behavioral health care is unlikely to fade anytime soon. While it will take time to build the trust necessary to make Measurement-Based Care fully effective, the potential benefits are significant—for both providers and patients. Data-informed clinicians can offer better care, adjust treatment plans when necessary, and track progress more accurately. Ultimately, the goal should be to ensure that MBC helps to enhance patient outcomes, not just provide another tool for financial oversight.
With a combination of increased transparency, better communication between clinicians and payers, and a shift toward more holistic metrics, Measurement-Based Care can truly revolutionize the way behavioral health is practiced. But for that to happen, building trust with providers and securing patient privacy must remain top priorities. Only then will the full potential of MBC be realized in the behavioral health space.
 has become a significant focus in the world of behavioral health, with growing adoption among..){kind=link}